S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
Secure your stake in the Smart Home industry. (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
Secure your stake in the Smart Home industry. (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
Secure your stake in the Smart Home industry. (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
Secure your stake in the Smart Home industry. (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
Secure your stake in the Smart Home industry. (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
Secure your stake in the Smart Home industry. (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
Secure your stake in the Smart Home industry. (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
Secure your stake in the Smart Home industry. (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners

Santhera Pharmaceuticals (SPHDF) Short Interest Ratio & Short Volume

$13.35
0.00 (0.00%)
(As of 11/28/2023 ET)
Compare
Today's Range
$13.35
$13.35
50-Day Range
$0.68
$13.35
52-Week Range
$9.40
$13.35
Volume
N/A
Average Volume
3,788 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Santhera Pharmaceuticals Short Interest Data

Current Short Volume
127,200 shares
Previous Short Volume
136,400 shares
Change Vs. Previous Month
-6.74%
Dollar Volume Sold Short
$1.70 million
Short Interest Ratio / Days to Cover
0.0
Last Record Date
November 15, 2023
Today's Trading Volume
0 shares
Average Trading Volume
3,788 shares
Today's Volume Vs. Average
0%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Santhera Pharmaceuticals ?

Sign up to receive the latest short interest report for Santhera Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SPHDF Short Interest Over Time

SPHDF Days to Cover Over Time

SPHDF Percentage of Float Shorted Over Time


Santhera Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/2023127,200 shares $1.70 million -6.7%N/A0 $13.35
10/31/2023136,400 shares $1.82 million +69.0%N/A104.9 $13.35
10/15/202380,700 shares $758,580.00 No ChangeN/A403.5 $9.40
9/30/202380,700 shares $54,876.00 -2.3%N/A403.5 $0.68
9/15/202382,600 shares $850,119.20 -0.2%N/A0 $10.29
8/31/202382,800 shares $56,304.00 -27.6%N/A10353.9 $0.68
8/15/2023114,300 shares $77,724.00 No ChangeN/A0 $0.68
6/30/20231,143,400 shares $7.78 million +254.3%N/A357.3 $6.80
6/15/2023322,700 shares $219,436.00 -7.4%N/A0 $0.68
5/31/2023348,500 shares $236,980.00 +20.5%N/A0 $0.68
5/15/2023289,200 shares $196,656.00 +18.5%N/A0 $0.68
4/30/2023244,000 shares $165,920.00 +0.1%N/A406.7 $0.68
4/15/2023243,800 shares $165,784.00 -3.1%N/A348.3 $0.68
3/31/2023251,700 shares $302,040.00 -28.4%N/A0 $1.20
3/15/2023351,500 shares $421,800.00 -0.7%N/A0 $1.20
2/28/2023354,000 shares $424,800.00 -10.1%N/A0 $1.20
2/15/2023393,700 shares $472,440.00 -1.9%N/A0 $1.20
1/31/2023401,500 shares $481,800.00 -1.6%N/A0 $1.20
1/15/2023407,900 shares $489,480.00 -27.8%N/A4079 $1.20
12/30/2022564,900 shares $796,509.00 +328.9%N/A282.5 $1.41
12/15/2022131,700 shares $185,697.00 +0.8%N/A0 $1.41
11/30/2022130,700 shares $184,287.00 No ChangeN/A0 $1.41
11/15/2022130,700 shares $184,287.00 No ChangeN/A0 $1.41
10/31/2022130,700 shares $184,287.00 No ChangeN/A0 $1.41
10/15/2022130,700 shares $184,287.00 +312.3%N/A130.7 $1.41
9/30/202231,700 shares $44,697.00 -97.0%N/A0 $1.41
9/15/20221,062,900 shares $1.50 million +8.1%N/A265.7 $1.41
8/31/2022983,000 shares $1.39 million +6.5%N/A0 $1.41
8/15/2022923,300 shares $1.30 million +4.5%N/A0 $1.41
7/31/2022883,700 shares $1.25 million -0.1%N/A0 $1.41
7/15/2022884,900 shares $1.25 million +0.1%N/A0 $1.41
6/30/2022883,700 shares $1.25 million No ChangeN/A0 $1.41
6/15/2022883,700 shares $1.25 million +0.1%N/A0 $1.41
5/31/2022882,700 shares $1.24 million -6.0%N/A0 $1.41
5/15/2022938,600 shares $1.32 million +2.4%N/A0 $1.41
4/30/2022916,500 shares $1.29 million +1.1%N/A0 $1.41
4/15/2022906,300 shares $1.28 million -5.5%N/A0 $1.41
3/31/2022959,500 shares $1.35 million +11.7%N/A0 $1.41
3/15/2022859,200 shares $1.21 million -10.6%N/A0 $1.41
2/28/2022960,700 shares $1.35 million +13.4%N/A0 $1.41













SPHDF Short Interest - Frequently Asked Questions

What is Santhera Pharmaceuticals' current short interest?

Short interest is the volume of Santhera Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 127,200 shares of SPHDF short. Learn More on Santhera Pharmaceuticals' current short interest.

Is Santhera Pharmaceuticals' short interest increasing or decreasing?

Santhera Pharmaceuticals saw a drop in short interest in November. As of November 15th, there was short interest totaling 127,200 shares, a drop of 6.7% from the previous total of 136,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Santhera Pharmaceuticals stock?

Short selling SPHDF is an investing strategy that aims to generate trading profit from Santhera Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Santhera Pharmaceuticals?

A short squeeze for Santhera Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SPHDF, which in turn drives the price of the stock up even further.

How often is Santhera Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPHDF, twice per month. The most recent reporting period available is November, 15 2023.



More Short Interest Resources from MarketBeat

This page (OTCMKTS:SPHDF) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -